Exposure to live saprophytic Leptospira before challenge with a pathogenic serovar prevents severe leptospirosis and promotes kidney homeostasis
Suman KunduiD, Advait B. ShettyiD, Maria J. C. Gomes-SoleckiiD
Abstract
Previous studies demonstrated that Leptospira biflexa, a saprophytic species, triggers innate immune responses in the host during early infection. This raised the question of whether these responses could suppress a subsequent challenge with pathogenic Leptospira. We inoculated C3H/HeJ mice with a single or a double dose of L. biflexa before challenge with a pathogenic serovar, L. interrogans serovar Copenhageni FioCruz (LIC). Pre-challenge exposure to L. biflexa did not prevent LIC dissemination and colonization of the kidney. However, it rescued weight loss and mouse survival thereby mitigating disease severity. Unexpectedly, there was correlation between rescue of overall health (weight gain, higher survival, lower kidney fibrosis marker ColA1) and higher shedding of LIC in urine. This stood in contrast to the L. biflexa unexposed LIC challenged control. Immune responses were dominated by increased frequency of effector T helper (CD4+) cells in spleen, as well as significant increases in serologic IgG2a. Our findings suggest that exposure to live saprophytic Leptospira primes the host to develop Th1 biased immune responses that prevent severe disease induced by a subsequent challenge with a pathogenic species. Thus, mice exposed to live saprophytic Leptospira before facing a pathogenic serovar may withstand infection with far better outcomes. Furthermore, a status of homeostasis may have been reached after kidney colonization that helps LIC complete its enzootic cycle. SignificancePrevious evidence of host innate immunity induced by live saprophytic Leptospira in mice led us to posit that these responses might mitigate leptospirosis severity upon a subsequent challenge with a pathogenic serovar. In this study, we validated our hypothesis. This is important for development of novel strategies to control leptospirosis and for understanding the epidemiologic risk factors of this and other infectious diseases transmitted by direct contact between pathogen and host. Unexpectedly, these studies also show that there is a correlation between kidney health after L. interrogans infection (less fibrosis marker ColA1) and higher shedding of this spirochete in urine. This suggests that a status of homeostasis may be reached after kidney colonization by L. interrogans that helps the spirochete fulfill its enzootic cycle.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 2.70
- Field percentile
- top 10%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- cGAS-STING dependent type I IFN protects against Leptospira interrogans renal colonization in mice.
Suman Gupta, James Matsunaga, … Fayyaz Shiraz Sutterwala·bioRxiv·Jun 2, 2025
- Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis
- Complement C3 Deficiency Enhances Renal Leptospiral Load and Inflammation While Impairing T Cell Differentiation During Chronic Leptospira interrogans Infection
Leonardo Moura Midon, Amaro Nunes Duarte Neto, … Lourdes Isaac·Infection and ImmunityPeer-reviewed·Nov 18, 2025
- Anti-Leptospira immunoglobulin profiling in mice reveals strain specific IgG and persistent IgM responses associated with virulence and renal colonization
F. Vernel-Pauillac, G. L. Murray, … C. Werts·bioRxiv·Nov 26, 2020
- Lethality of leptospirosis depends on sex: male hamsters succumb to infection with lower doses of pathogenic Leptospira
Charles K. Gomes, Mariana Guedes, … Maria Gomes-Solecki·bioRxiv·May 15, 2018
- L.interrogans prevents macrophage death and pyroptotic IL1β release through its lipopolysaccharide
D. Bonhomme, V. Hernandez-Trejo, … C. Werts·bioRxiv·Jul 25, 2022